Evidence map›Paper›PMID 32258020›Full record

ArticleOcular oncology and pathology2020

p16 Expression Correlates with Invasive Ocular Surface Squamous Neoplasms in HIV-Infected Mozambicans.

Carla Carrilho, Chau Miu, Yeji Kim, Susan Karki, Alexandra Balmaceda, Bindu Challa, Scott Diamond, Eliane Monteiro, Evelia Marole, Cesaltina Lorenzoni and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Ocular oncology and pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Case report: Squamous cell carcinomaFrontiers in medicine · 2024
    Article
  3. Article
  4. Article
  5. Conjunctival cancer in people living with HIV.Current opinion in infectious diseases · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Carla CarrilhoDepartment of Pathology, Eduardo Mondlane University, Maputo, Mozambique.
Chau MiuDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Yeji KimDepartment of Ophthalmology, University of California San Diego, La Jolla, California, USA.
Susan KarkiDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Alexandra BalmacedaDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Bindu ChallaDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Scott DiamondDepartment of Pathology, University of California Los Angeles, Los Angeles, California, USA.
Eliane MonteiroService of Pathology, Maputo Central Hospital, Maputo, Mozambique.
Evelia MaroleService of Ophthalmology, Maputo Central Hospital, Maputo, Mozambique.
Cesaltina LorenzoniDepartment of Pathology, Eduardo Mondlane University, Maputo, Mozambique.
Yolanda ZambujoService of Ophthalmology, Maputo Central Hospital, Maputo, Mozambique.
Yu-Tsueng LiuDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Robert T SchooleyDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Jonathan H LinService of Pathology, Maputo Central Hospital, Maputo, Mozambique.
University of California San Diego · USMaputo Central Hospital · MZEduardo Mondlane University · MZUniversity of California, Los Angeles · USVA Palo Alto Health Care System · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Radha Ayyagari · 2012 to 2026
$10.3M
Enhanced Advanced Biomedical Research Training for MozambiqueD43TW010135 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2015 to 2019
$3.2M
FIC NIH HHS D43 TW010135NCATS NIH HHS UL1 TR001442NCI NIH HHS P30 CA023100NEI NIH HHS P30 EY022589NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

backgroundp16 immunohistochemistry is widely used to diagnose human papillomavirus (HPV)-related squamous neoplasms of cervix, anogenital, head, and neck tissues. The incidence of these HPV-related squamous neoplasms is markedly increased in the HIV-infected population. Ocular surface squamous neoplasia (OSSN) is also more common in HIV-infected patients. However, the expression pattern of p16 in OSSN among HIV-infected patients is unclear. Here, we examined the expression of p16 in OSSN surgical excisions collected from a large HIV-infected cohort from -Mozambique.

methodsOSSN surgical tissue specimens were collected from 75 Mozambican patients. Formalin-fixed, paraffin-embedded tissue blocks from these OSSNs were sectioned, stained with hematoxylin and eosin (H&E), and p16 expression by immunohistochemistry. H&E slides were reviewed to determine if OSSNs were noninvasive conjunctival intraepithelial neoplasms or invasive squamous cell carcinomas (SCC). Cases were classified as p16 positive or negative based on diffuse nuclear and cytoplasmic expression of p16 in neoplastic cells.

resultsp16 positivity was found in a minority of OSSN cases (14/75). p16 positivity was significantly associated with the invasive SCC type of OSSN in HIV-infected patients (

conclusionsThe majority of OSSNs in our HIV-infected cohort do not express p16. However, those cases that are p16-positive are significantly more likely to be the invasive SCC form of OSSN. We propose that p16 expression may identify more aggressive OSSNs in HIV-infected populations.

Indexed as

HIVHuman papillomavirusOcular surface squamous neoplasiap16 immunohistochemistry

Identifiers

PMID32258020
PMCPMC7109427
OpenAlexW2971752113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.